Home / Inspections / 1245297

FDA Inspection 1245297 — Armstrong Pharmaceuticals, Inc.

Armstrong Pharmaceuticals, Inc. — FEI 3007009553

The FDA completed an inspection of Armstrong Pharmaceuticals, Inc. on July 19, 2024 in Canton, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 19, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Canton, MA (United States)

Additional Details

Bioanalytical BA/BE

Facility

Other inspections at this facility

  • 1316472 (VAI Fri May 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1147623 (NAI Wed Jul 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 872285 (NAI Thu Apr 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 805461 (NAI Fri Oct 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 785248 (VAI Thu Jun 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources